Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer
Cynthia X. Ma, Suresh Nair, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, Alex A. Adjei
Dive into the research topics of 'Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.